ERES East Resources Acquisition Company

eResearchTechnology Issued a United States Patent For Methods and Systems for Processing Electrocardiograms Patent Includes More than 50 Claims Associated With eRT's Digital ECG Processing Environment and EXPeRT(R) System and Methods PHILADELPHIA, June 2 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (NASDAQ:ERES), a leading provider of centralized electrocardiographic collection and interpretation services, announced today that it has been issued United States Patent No. 6,708,057 (the '057 Patent) for various methods and systems for processing electrocardio grams. The methods and systems have particular utility in the collection and interpretation of electrocardiograms developed during clinical trials. The '057 Patent includes more than 50 claims directed to various features of eRT's EXPeRT(R) workflow enabled data handling technology, the first solution in production that was designed explicitly to meet emerging international regulatory guidance and technical standards. eRT's EXPeRT(R) system provides integrated technology and processes across the entire lifecycle of a digital ECG transaction, from collection, to analysis, management and distribution of results. Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development. Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors and technological development. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Forms 10-K and 10-Q filed with the Securities and Exchange Commission. DATASOURCE: eResearchTechnology, Inc. CONTACT: Joan Sterlacci of eResearchTechnology, +1-908-203-6473, or Matt Hayden of Hayden Communications, +1-858-456-4533, for eResearchTechnology Web site: http://www.ert.com/

Copyright